Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 16,667 | reported | 13 Oct 2023 | tx 9+224,293−2,527 |
| Lantheus Holdings, Inc. | 7,237 | reported | 14 May 2026 | tx 6+13,812 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Lantheus Holdings, Inc. | 4,137 | 0.00 USD | |
| 14 May 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 2,537 | 0.00 USD | |
| 14 May 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 4,543 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 563 | 0.00 USD | |
| 07 Feb 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 1,017 | 0.00 USD | deriv |
| 13 Oct 2023 | GRANT_AWARD | CRISPR Therapeutics AG | 16,667 | 0.00 USD | deriv |
| 23 May 2023 | EXERCISE | CRISPR Therapeutics AG | 6,938 | — | |
| 24 May 2023 | TAX_WITHHOLDING | CRISPR Therapeutics AG | 2,527 | 65.91 USD | |
| 23 May 2023 | EXERCISE | CRISPR Therapeutics AG | 6,938 | — | deriv |
| 10 Mar 2023 | GRANT_AWARD | CRISPR Therapeutics AG | 22,000 | 0.00 USD | deriv |
| 10 Mar 2023 | GRANT_AWARD | CRISPR Therapeutics AG | 44,620 | 0.00 USD | deriv |
| 07 Oct 2022 | GRANT_AWARD | CRISPR Therapeutics AG | 9,380 | 0.00 USD | deriv |
| 23 May 2022 | GRANT_AWARD | CRISPR Therapeutics AG | 27,750 | 0.00 USD | deriv |
| 23 May 2022 | GRANT_AWARD | CRISPR Therapeutics AG | 90,000 | 0.00 USD | deriv |